AzTrials
AzTrials

Adult Spinal DeformityNCT02035280

Prospective Evaluation of Elderly Deformity Surgery

An observational study of Adult Spinal Deformity, run by AO Foundation, AO Spine at 13 sites in 8 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

As the population continues to age, the prevalence of spinal deformity surgery for older patients is increasing. Questions regarding the suitability of these patients to undergo large spinal procedures and whether the outcomes merit the risks involved are not well known. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Adult Spinal Deformity
How many people
233 participants
Where
13 sitesin 8 countries
Study dates
Dec 2013to Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Elderly patients undergoing elective surgery for spinal deformity

Who may be able to join

  • Age 60 years or older at the time of surgery
  • Diagnosis of adult spinal deformity either in the coronal or sagittal plane requiring at the minimum a 5-level spinal fusion procedure
  • Ability to understand the content of the patient information / Informed Consent Form
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated Institutional Review Board (IRB)/Ethics Committee (EC)-approved written informed consent
  • Reconsent of patients for the 5 year follow-up if required by the IRB/EC

Who cannot join

  • Any previous spinal procedure (except prior decompression of a maximum of 2 levels)
  • Neurodegenerative disease or paralysis
  • Unlikely to comply with follow-up
  • Institutionalized individuals
  • Any not medically managed severe systemic disease
  • Recent history (≤ 3 months) of substance abuse (ie, recreational drugs, alcohol) or psychosocial disturbance that would preclude reliable assessment
Show all 11Show fewer
  • Prisoner
  • Presence of active malignancy
  • Has active, overt bacterial infection, systemic or local
  • History of recent(≤ 3 months) fracture/malignancy in the spinal region
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Trial locations and contacts

13 sites in 8 countries.

13 sites in 8 countries

United States5 sites
  • University of Virginia

    Charlottesville, Virginia, 22903

  • University of Minnesota

    Minneapolis, Minnesota, 55454

  • New York Presbyterian - Columbia University Medical Center

    New York, New York, 10032

  • UCSF Medical Center

    San Francisco, California, 94118

  • Washington University Orthopedics

    St Louis, Missouri, 63110

Other trials in United States

China2 sites
  • Queen Mary Hospital

    Hong Kong

  • Nanjing University Medical School

    Nanjing

Other trials in China

Canada1 site
  • Toronto Western Hospital

    Toronto, Ontario

Other trials in Canada

Denmark1 site
  • Rigshospitalet

    Copenhagen

Other trials in Denmark

Japan1 site
  • Hamamatsu University School of Medicine

    Hamamatsu

Other trials in Japan

Netherlands1 site
  • St. Maartens Kliniek

    Nijmegen

Other trials in Netherlands

Spain1 site
  • Hospital Vall d'Hebron

    Barcelona

Other trials in Spain

Turkey (Türkiye)1 site
  • Aciboden Maser Hospital

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Prospective Evaluation of Elderly Deformity Surgery: A Prospective Observational, Multicenter Study

As the population continues to age, the prevalence of spinal deformity surgery for older patients is increasing. Questions regarding the suitability of these patients to undergo large spinal procedures and whether the outcomes merit the risks involved are not well known.

Read the detailed description

225 subjects greater than or equal 60 years of age with moderate and severe adult spinal deformity requiring surgical correction will be enrolled in a prospective multicenter international study. Spinal deformity will be defined as any coronal or sagittal plane spinal deformity in patients who have not undergone any previous spinal surgery (with the exception of prior decompression of a maximum of 2 levels) necessitating at a minimum a 5-level spinal fusion procedure. Standard radiographs and cross sectional imaging will be performed preoperatively, postoperatively, at 24 months and 5 years after surgery. Preoperative disease specific and general health questionnaires will be completed by all patients (EQ-5D, ODI, SRS-22r, NRS for back and leg pain). Follow up visits with questionnaires will be performed at 10 weeks (± 6 weeks), 12 months (± 2 months), 24 months (± 2 months) and 5 years (±6 months) post-operatively. All treatment-related AEs will be documented.

Regression analyses will be used to evaluate the association between patient demographics, comorbidities, treatment history, spinal deformity characteristics, surgical characteristics, treatment-related AEs and pre-surgical status to self-reported and radiographic outcomes after surgery.

Keywords
Spine, Deformity, Fusion, Elderly, SRS-22r
Medical subject headings
Congenital Abnormalities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02035280
Study groupRoleWhat they receive
Elderly suffering of spine deformitySpinal deformity patients over the age of 60 years undergoing elective surgery and requiring fusion of at least 5 levels.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Absolute change in the Scoliosis Research Society-22 r (SRS-22r) total score

    The primary outcome is the absolute change in the SRS-22r total score between baseline and 24-months follow-up (FU) values in patients at age 60 or older treated with major spinal reconstruction.

    The SRS-22r is a patient-reported outcome instrument and has a range from 1 (worst) to 5 (best). It contains 22 questions covering five domains: function, pain, self-image, mental health (each with 5 items), and satisfaction with treatment (2 items) and each item is scored from 1 to 5.

    Measured: Baseline, 10 weeks, 12 months, 24 months

Secondary outcomes (8)
  1. Treatment-related adverse events

    Measured: Surgery, 10 weeks, 12 months, 24 months, 5 years

  2. Oswestry Disability Index Version 2.1a (ODI)

    The outcome measure is the absolute change between baseline, the 24-month and the 5-year FU values.

    The ODI is a patient-reported outcome measure used most commonly in patients with low back pain. It consists of 10 questions and each of the items can be scored from 0 (no disability) to 5 (maximal disability), leading to a maximum score of 50.

    Measured: Baseline, 10 weeks, 12 months, 24 months, 5 years

  3. EuroQoL5 (EQ-5D).

    The EQ-5D is a standardized instrument designed for self-completion to assess quality of life. It has 5 items with a three-point categorical response scale. A unique EQ-5D health state is defined by combining one level from each of the five dimensions.

    The EQ-5D is a standardized instrument designed for self-completion to assess quality of life. It has 5 items with a three-point categorical response scale. A unique EQ-5D health state is defined by combining one level from each of the five dimensions.

    Measured: Baseline, 10 weeks, 12 months, 24 months, 5 years

  4. Pain (back and pain)

    The outcome measure is the absolute change between baseline,the 24-month and 5 year FU values.

    Lower back and leg pain will be assessed on a visual analogue scale (NRS) which ranges from 0 (no pain) to 100 (severe pain).

    Measured: Baseline, 10 weeks, 12 months, 24 months, 5 years

  5. Bone Mineral Density (BMD)

    Baseline dual energy x-ray absorptiometry (DXA) scans of patients' BMD will only be performed at clinics where assessed as standard of care.

    Measured: Baseline

  6. Radiological Parameters

    Radiological paramaters (lumbar lordosis, thoracic kyphosis, sagittal vertical axis, Cobb angle) will be measured at one pre- and two post-OP timepoints from sagittal standing and coronal standing x-rays.

    Measured: Baseline, Surgery, 24 months, 5 years

  7. Animal Fluency Test

    The animal fluency test is a diagnostic tool that is recommended for use in clinical practice for quick assessment of cognitive impairment. The patient names as many animals as possible within a 60-second time period. Fifteen or fewer animals may indicate development of cognitive impairment.

    Measured: Baseline, 10 weeks, 12 months, 24 months, 5 years

  8. SRS-22r

    The SRS-22r is a patient-reported outcome instrument and has a range from 1 (worst) to 5 (best). It contains 22 questions covering five domains: function, pain, self-image, mental health (each with 5 items), and satisfaction with treatment (2 items) and each item is scored from 1 to 5.

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2014 (estimated)
  2. Study startDec 2013
  3. Primary completionDec 2021
  4. Study completionDec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
233 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02035280
Sponsor's protocol ID
PEEDS
Status last verified
Jul 2023
First submitted
19 Dec 2013
Last updated
28 Jul 2023
Results posted
No
Data monitoring committee
Yes

Publications

  • Campos Daziano M, Daunt L, Vashishth V, Seider E, Abbas A, Rienmueller A, Matsuyama Y, Qiu Y, Kelly M, Smith JS, Dahl BT, Spruit M, de Kleuver M, Polly DW, Sembrano J, Pellise-Urquiza F, Cheung KMC, Alanay A, Lenke LG, Shaffrey CI, Berven SH, Lewis SJ; PEEDS Study Group and AO Spine Knowledge Forum Deformity. Can Social Function Improve in Older Patients Undergoing Multi-Level Spinal Deformity Surgery? Global Spine J. 2026 Jul;16(6):2601-2610. doi: 10.1177/21925682251411237. Epub 2025 Dec 27.

    PubMed 41454904

Questions about this trial

What is this clinical trial studying?

An observational study of Adult Spinal Deformity, run by AO Foundation, AO Spine at 13 sites in 8 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 13 sites in United States, China, Canada, Denmark, Japan and 3 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Absolute change in the Scoliosis Research Society-22 r (SRS-22r) total score (time frame: Baseline, 10 weeks, 12 months, 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02035280, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in